Details of the Drug

General Information of Drug (ID: DMVUZE6)

• Drug Name: GZ17-6.02

Indication

Disease Entry	ICD 11	Status	REF
Lymphoma	2A80-2A86	Phase 1	[1]
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]

• Cross-matching ID: TTD ID: DK5JP3
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] ClinicalTrials.gov (NCT03775525) Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or Lymphoma (GEN602). U.S. National Institutes of Health.